Search Results 111-120 of 21366 for anti-TNF drugs

1. centers-of-excellence

   Adalimumab-Adbm (Subcutaneous Route) Before Using - Mayo Clinic. Skip to content Care at Mayo Clinic Patient-Centered Care About Mayo ...

2. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

   Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...

3. Inflammatory bowel disease biobank research update - Mayo Clinic

   ... anti-tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses ...

4. Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients - Mayo Clinic News Network

   Researchers tested blood samples taken before rheumatoid arthritis treatment was given. The patients then were treated with anti-inflammatory biologic drugs ...

5. Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease - Mayo Clinic

   ... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...

6. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

7. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

   ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

8. Clinical Trials - Mayo Clinic Research

   Drugs & Supplements A-Z · Health Books · Healthy Living Program ... Title: A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab ...

9. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

   ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...

10. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    Additionally, some of these drugs are weight-based, while others are fixed doses. ... Examining clinical and genetic factors that impact response to anti-TNF ...